ProCE Banner Activity

The Art of Starting ART: Individualizing HIV Care From the Beginning

Clinical Thought

Knowing when to initiate ART is more straightforward, but selecting the right treatment regimen can be complicated. Read my commentary on deciding between preferred 2- and 3-drug regimens while considering presence of coinfections, comorbidities, and individual preferences.

Released: August 30, 2023

Share

Faculty

Janine Trevillyan

Janine Trevillyan, MBBS, PhD, FRACP

Associate Professor
Department of Infectious Diseases
Peter Doherty Institute of Infection and Immunity at University of Melbourne
Head, Clinical Virology and HIV Services
Deputy Director
Department of Infectious Diseases
Austin Health
Melbourne, Victoria

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC, Rahway, NJ, USA.

Merck Sharp & Dohme LLC, Rahway, NJ, USA

Disclosure

Primary Author

Janine Trevillyan, MBBS, PhD, FRACP

Associate Professor
Department of Infectious Diseases
Peter Doherty Institute of Infection and Immunity at University of Melbourne
Head, Clinical Virology and HIV Services
Deputy Director
Department of Infectious Diseases
Austin Health
Melbourne, Victoria

Janine Trevillyan, MBBS, PhD, FRACP: consultant/advisor/speaker: Gilead Health Sciences.